General Information
Revision date
2001-11-28
Product name
Daunomycin Hydrochloride
1.2.1 Relevant identified uses
Antineoplastic
Manufacturer Name
American Pharmaceutical Partners, Inc
Icons in SDS
Company Information
company name
American Pharmaceutical Partners, Inc
Section 2
SECTION 2: Hazards identification
Principle Routes of Exposure
Inhalation, Eye/Skin Absorption and Ingestion This material is a suspect carcinogen, and is possibly mutagenic and teratogenic: See also Section 11. COMPONENT CAS No. NTP IARC